A 75-year-old man with interstitial pneumonia due to ANCA-related vasculitis requiring immunosuppressive treatment was admitted to our hospital because of fever and rapidly progressive dyspnea. Chest CT showed diffuse ground-glass opacity with infiltration shadow in the bilateral lungs. We established a definitive diagnosis by isolating Mycobacterium massiliense on culture examination of acid-fast bacilli from peripheral blood and sputum. We began to administer CAM, LVFX, AMK, IPM/CS to this patient two weeks after admission. However, he died of respiratory failure and septic shock. There are few case reports of pulmonary lesion with septicemia due to Mycobacterium massiliense.
Introduction
Rapidly growing mycobacterium infections are increasing in the United States (1), but the specific organisms are difficult to identify by conventional methods. Mycobacterium massiliance (M. massiliance) has been distinguished from Mycobacterium abscessus (M. abscessus) by sequencing of a 723-bp fragment of the RNA polymerase β subunit (rpoB) gene (2) . Because this technique is available in relatively few clinical laboratories, cases of infection with M. massiliense may be mistakenly attributed to M. abscessus.
We encountered a peculiar case in which M. massiliense was isolated from peripheral blood and sputum during immunosuppressive treatment for ANCA-related vasculitis. To our knowledge, this is the second reported case of lethal pulmonary M. massiliense disease with septicemia (3).
Case Report
A 75-year-old man was admitted to our hospital because of fever and rapidly progressive dyspnea. He had been diagnosed as having interstitial pneumonia due to ANCA-related vasculitis three months earlier and administration of immunosuppressive drugs was immediately initiated (methylprednisolone 1 g/day for three days and subsequently prednisolone 40 mg/day for two weeks) by the previous hospital. Thereafter, the dose of prednisolone was decreased by 5 mg/ day every two weeks and maintained at 20 mg/day until admission to our hospital. His clinical findings and abnormal radiograph findings were improved. Prevention therapy for immunosuppressive treatment was performed with sulfametoxazol/trimetoprim (ST), but not isoniazid (INH) during the administration of prednisolone. He had a smoking history of 20 cigarettes/day for forty years. On physical examination, coarse crackle was auscultated over the bilateral lung fields. Laboratory data on admission is shown in Table 1 . Slight anemia, moderate inflammatory response, hypoalbuminemia, mild liver and renal dysfunction, and severe hypoxia were recognized. Purified protein derivatives (PPD) and QuantiF-ERON TB-Gold test showed negative responses. Chest radiograph showed diffuse interstitial shadows in the bilateral lung fields with infiltration shadows in the bilateral middle and lower lung fields (Fig. 1) . Computed tomography (CT) of the chest showed diffuse linear and reticular shadows in the bilateral lungs with consolidation shadows in the bilat- (Fig. 2) .
We present the clinical course of this patient in Fig. 3 .
We initially diagnosed the patient as having bacterial pneumonia and exacerbation of interstitial pneumonia with ANCA-related vasculitis. Therefore, two antimicrobial drugs (MEPM and CPFX) and steroid pulse therapy (methylprednisolone 1 g/day for three days) were administered to this Gram-positive bacilli were identified five days later from routine blood culture and acid-fast bacilli were cultured two weeks later on Ogawa egg medium slants. We changed the antituberculous treatment to combination chemotherapy consisting of clarithromycin (CAM), amikacin (AMK), imipenem/cilastatin (IPM/CS) and levofloxacin (LVFX) because of the rapidly spreading mycobacterial infection thought to be caused by M. abscessus. Finally, genotypic analysis of 16S rRNA, hsp65, rpoB genes and the 16S-23S rRNA internal transcribed spacer sequence of the isolates from peripheral blood and sputum identified M. massiliense (genotype analysis of rpoB genes: Fig. 4 ). Drug sensitivity test using the Brothmic NTM method (Japan) for M. massiliense was characterized by high MIC to most antimicrobial drugs tested. The isolate was sensitive only to clarithromycin (CAM) ( Table 2) . However, the clinical response was poor and the patient died of respiratory failure one week after the initiation of combination therapy. Because we could not perform an autopsy, it was difficult to determine the cause of respiratory failure in this patient.
Discussion
We report the second case of pulmonary M. massilliense disease with septicemia during immunosuppressive therapy (3). M. massiliense is a rapidly growing mycobacterium species, similar to M. abscessus, M. bolletii and M. chelonae. Therefore, although it was previously difficult to distinguish these four strains, genetic sequencing using rpoB (Fig. 4) , hsp65 and 16S-23S rRNA ITS gene sequence analyses has facilitated discrimination of these four strains (4-7). In this patient, because the sequencing showed 100% homology with M. massiliense, we correctly identified the causative microorganism.
Regarding the radiological features of pulmonary disease caused by rapidly growing mycobacteria (the causative microorganism was M. abscessus in most of these cases), Griffith et al indicated that the most frequent patterns were interstitial, interstitial/alveolar, and/or reticulonodular, while cavitation was an unusual consequence of rapidly growing mycobacterial disease occurring in only 16% of cases. The extension of the lesion was typically multilobar with the greater proportion involving three or more lobes and demonstrating bilateral involvement (8) . In recent reports, radiological findings of pulmonary M. abscessus disease showed bilateral reticulonodular shadow patterns without cavity on chest radiograph and bronchiectatic lesion and multiple small nodular shadows (<5 mm) on chest CT (9, 10) . These findings resembled those of cases showing pulmonary Mycobacterium avium complex (MAC) disease. Although there are no reports describing the radiological findings of pulmo- nary M. massiliense disease because reports of such cases are rare, we speculate that cases of pulmonary M. massiliense disease were included among those of rapidly growing mycobacterial disease. The radiological findings of the present case showed diffuse interstitial shadows complicated with ANCA-related interstitial pneumonia with infiltration shadows resembling pneumonia in the bilateral lung field without cavity formation. However, because we could not perform an autopsy, it is difficult to correctly assess the radiological characteristics and determine the lesion extension due to pulmonary M. massiliense disease in the present case. There are two possibilities; one is that the pulmonary lesions were due to pulmonary infection of M. massiliense and the other is that the pulmonary lesions were due to acute respiratory distress syndrome (ARDS) secondary to sepsis caused by M. massiliense. The extended pulmonary lesion was suspected to have been influenced by long-term immunosuppressive treatment.
Concerning the drug sensitivity test for nontuberculous mycobacteria (NTM), we adopted the Broth MIC NTM method (Kyokuto Pharmaceutical Company, Tokyo, Japan). However, the results were not sufficiently reliable except that CAM for NTM disease and only CAM showed a sensitive MIC for pulmonary M. massiliense disease with septicemia. In the present case, the clinical response to combined therapy (CAM, IPM/CS, AMK, LVFX) was poor despite administration of a treatment regimen similar to that for M. abscessus disease according to the ATS guidelines (11) . Although we previously reported cases of pulmonary M. abscessus disease showing a good clinical response to combined therapy (12) , the recommended therapy for M. massiliense disease has not yet been established in the ATS guidelines because there have been so few cases of pulmonary M. massiliense disease accumulated to date. Because cases of infection with M. massiliense are suspected to have been included among reported cases of M. abscessus infection, we think that the frequency of isolating M. massiliense will increase with advances in microbiological technology in the future.
In conclusion, we encountered a case of severe pulmonary M. massiliense disease with septicemia that required differentiation from pneumonia during immunosuppressive treatment for ANCA-related vasculitis. It is important that we pay attention to the appearance of rapidly growing mycobacterial infection such as not only M. abscessus but also M. massiliense during long-term immunosuppressive treatment and perform repeated fast-acid bacilli examinations even if the patient shows atypical clinical findings such as in this case.
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